Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Séverine Carillon, Gabrièle Laborde-Balen, Maïmouna Diop, Karim Diop, Guillaume Breton, Bara Ndiaye & Bernard Taverne. (2023) Implementing long-acting injectable antiretroviral treatments in Senegal: issues, challenges and conditions for introducing them. Qualitative study with healthcare providers and patients. AIDS Care 0:0, pages 1-7.
Read now
Read now
Lorraine Sherr, Richard Harding, Udi Davidovich, Lucie Cluver, Bruno Spire, Bridgette Prince, Barbara Hedge & Jose Catalan. (2020) AIDSImpact 2019 special issue – Promises to keep and miles to go … . AIDS Care 32:sup2, pages 1-4.
Read now
Read now
Articles from other publishers (15)
Jesse G. O'Shea, Preetam Cholli, Emily L. HeilKate Buchacz. (2023) Considerations for long-acting antiretroviral therapy in older persons with HIV. AIDS 37:15, pages 2271-2286.
Crossref
Crossref
Thijs Reyniers, Marion FiorentinoStéphane Alain Yoro BaboMamadou OuedraogoIbrahima KantaLaurette Ekon AgbegniganDaniela RojasCamille AnomaTer Tiero Elias DahEphrem MensahBintou Dembélé KeitaBruno SpireBea VuylstekeChristian Laurent. (2023) The Perceived Added Value of Bimonthly Injectable Pre-Exposure Prophylaxis According to West African Men Who Have Sex with Men: A Focus Group Study. AIDS Patient Care and STDs 37:10, pages 480-488.
Crossref
Crossref
Anne M. Masich, Denese Gomes, Robert T. Higginson, Zara Morgan, Daniel NixonMelissa Tran, Elizabeth Winthrop & Patricia P. Fulco. (2023) HIV virologic response and baseline genotypic resistance in a long-acting cabotegravir/rilpivirine initiation program. AIDS 37:10, pages 1641-1642.
Crossref
Crossref
Elona Toska, Siyanai Zhou, Jenny Chen-Charles, Lesley Gittings, Don Operario & Lucie Cluver. (2023) Factors Associated with Preferences for Long-Acting Injectable Antiretroviral Therapy Among Adolescents and Young People Living with HIV in South Africa. AIDS and Behavior 27:7, pages 2163-2175.
Crossref
Crossref
Lara Lorenzetti, Nhi Dinh, Ariane van der Straten, Virginia Fonner, Kathleen Ridgeway, Michelle Rodolph, Robin Schaefer, Heather‐Marie A. Schmidt & Rachel Baggaley. (2023) Systematic review of the values and preferences regarding the use of injectable pre‐exposure prophylaxis to prevent HIV acquisition. Journal of the International AIDS Society 26:S2.
Crossref
Crossref
Laurence Slama, Raphael Porcher, Françoise Linard, Catherine Chakvetadze, Agnès Cros, Séverine Carillon, Lucille Gallardo, Jean-Paul Viard & Jean-Michel Molina. (2023) Injectable long acting antiretroviral for HIV treatment and prevention: perspectives of potential users. BMC Infectious Diseases 23:1.
Crossref
Crossref
Alfredo Soler Carracedo, Vitor Oliveira, Jorge Saz, Ferran Pujol, Ana Milinkovic & Allison Webel. (2022) Multi-tablet, Single-Tablet, or Long-Acting Antiretroviral Treatment for HIV: A Cross-sectional Study of Patient Preferences in the United States and Spain. Journal of the Association of Nurses in AIDS Care 33:6, pages 638-645.
Crossref
Crossref
Lauren F Collins, Della Corbin-Johnson, Meron Asrat, Zoey P Morton, Kaylin Dance, Alton Condra, Kimberly Jenkins, Marie Todd-Turner, Jeri Sumitani, Bradley L Smith, Wendy S Armstrong & Jonathan A Colasanti. (2022) Early Experience Implementing Long-Acting Injectable Cabotegravir/Rilpivirine for Human Immunodeficiency Virus-1 Treatment at a Ryan White-Funded Clinic in the US South. Open Forum Infectious Diseases 9:9.
Crossref
Crossref
Sarah Demart. (2022) « On n’arrive pas à les toucher » : la PrEP, les migrant.e.s africain.e.s et la production de l’ignorance. Global Health Promotion 29:3, pages 151-154.
Crossref
Crossref
Christia Palacios, Celine Wilpotte, Anne Adda, Salima Allaf, Peline Thibaut, Julie Chas, Martin Siguier & Gilles Pialoux. (2022) Expectations and acceptability of long-acting injectable antiretrovirals by patients living with HIV/AIDS. Infectious Diseases Now 52:4, pages 238-239.
Crossref
Crossref
Omar Sued, Norma Nardi & Luciana Spadaccini. (2022) Key population perceptions and opinions about long-acting antiretrovirals for prevention and treatment: a scoping review. Current Opinion in HIV and AIDS 17:3, pages 145-161.
Crossref
Crossref
AWOLU ADAM, ADAM FUSHEINI, FAITH A AGBOZO, GEOFFREY ADEBAYO ASALU, MARTIN AMOGRE AYANORE, NORBERT AMUNA, PRINCE KUBI APPIAH, SENAM ABENA KLOMEGAH & FRANCIS BRUNO ZOTOR. (2022) Impact of antiretroviral therapy regimens adherence on perceived health and wellbeing status among adults living with HIV in Ghana. F1000Research 11, pages 208.
Crossref
Crossref
Babatunde Akinwunmi, Daniel Buchenberger, Jenny Scherzer, Martina Bode, Paolo Rizzini, Fabio Vecchio, Laetitia Roustand, Gaelle Nachbaur, Laurent Finkielsztejn, Vasiliki Chounta & Nicolas Van de Velde. (2021) Factors associated with interest in a long-acting HIV regimen: perspectives of people living with HIV and healthcare providers in four European countries. Sexually Transmitted Infections 97:8, pages 566-573.
Crossref
Crossref
Babatunde Akinwunmi, Daniel Buchenberger, Jenny Scherzer, Martina Bode, Paolo Rizzini, Fabio Vecchio, Laetitia Roustand, Gaelle Nachbaur, Laurent Finkielsztejn, Vasiliki Chounta & Nicolas Van de Velde. (2021) Dose-related and contextual aspects of suboptimal adherence to antiretroviral therapy among persons living with HIV in Western Europe. European Journal of Public Health 31:3, pages 567-575.
Crossref
Crossref
Anak Agung Sagung Sawitri, I Nyoman Sutarsa, Ketut Tuti Parwati Merati, I Made Bakta & Dewa Nyoman Wirawan. (2021) Why Counseling Intervention Fails to Improve Compliance towards Antiretroviral Therapy: Findings from a Mixed-Methods Study among People Living with HIV in Bali Province, Indonesia. Infectious Disease Reports 13:1, pages 136-147.
Crossref
Crossref
![Supercharge Your Next Research Paper: Research and write your next paper with Jenni AI.]({"type":"image" , "src" : "/sda/112443/Skyscraper-socialsciences.png"})